project id: TCGA-HNSC; case submitter id: TCGA-QK-A8ZB; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.78; rna integrity number: 8.8; age at index: 68; days to birth: -25192; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1945; age at diagnosis: 25192; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IVA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 542.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 30; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-QK-A8ZB-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 70.0;